Intestinal Barrier in Post- Campylobacter jejuni Irritable Bowel Syndrome

Biomolecules. 2023 Feb 28;13(3):449. doi: 10.3390/biom13030449.

Abstract

Background: Campylobacter jejuni (C. jejuni) is one of the most common causes of bacterial gastroenteritis worldwide. One sequela of this infection is the development of post-infectious irritable bowel syndrome (PI-IBS). It has been suggested that a dysfunctional intestinal barrier may promote IBS development. We aimed to test this hypothesis against the background of the leaky gut concept for low-grade inflammation in PI-IBS.

Methods: We identified patients with persistent PI-IBS symptoms after C. jejuni infection. During sigmoidoscopy, forceps biopsies were obtained for electrophysiological measurements of epithelial transport and barrier function in miniaturized Ussing devices. C. jejuni absence was checked by PCR and cytokine production with immunohistochemistry.

Results: In PI-IBS, the epithelial resistance of the colon epithelium was unaltered, reflecting an intact paracellular pathway. In contrast, temperature-dependent horseradish peroxidase (HRP, 44 kDa) permeation increased. Short-circuit current (Isc) reflecting active anion secretion and ENaC-dependent electrogenic sodium absorption was unaffected. Early endosome antigen-1 (EEA1) and IL-4 levels increased. C. jejuni is not incorporated into the resident microbiota of the colon mucosa in PI-IBS.

Conclusions: In PI-IBS after C. jejuni infection, macromolecule uptake via endocytosis was enhanced, leading to low-grade inflammation with pro-inflammatory cytokine release. The findings will allow C. jejuni-induced pathomechanisms to be targeted during infection and, thereafter to reduce sequelae such as PI-IBS.

Keywords: Campylobacter jejuni; antigen entry; barrier function; cytokine; endocytosis; irritable bowel syndrome; leaky gut; permeability; post-infectious irritable bowel syndrome; tight junction; transcytosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Campylobacter Infections* / complications
  • Campylobacter Infections* / microbiology
  • Campylobacter jejuni* / metabolism
  • Cytokines / metabolism
  • Humans
  • Inflammation / complications
  • Irritable Bowel Syndrome* / microbiology

Substances

  • Cytokines

Grants and funding

This research was funded by the Deutsche Forschungsgemeinschaft (Schu 559/11-5–175142815 and GRK 2318–318905415 (C01)) and the Sonnenfeld-Stiftung Berlin. This research was partly supported by the German Federal Ministry of Education and Research (BMBF) in frame of the zoonoses research consortium PAC-Campylobacter (project IP2/01KI2007A and project IP8/01KI2007D).